In this Q&A, LENZ CFO Dan Chevallard on Vizz's ECP momentum, telehealth expansion, and the global push to end reading glasses for presbyopia.
Dan Chevallard, CFO, LENZ Therapeutics
Advertisement
Articles by Dan Chevallard, CFO, LENZ Therapeutics
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Bausch + Lomb's BL1107 fails primary end point in Phase 2 glaucoma trial
2
Alcon launches digital campaign to reintroduce LASIK to Gen Z
3
The influence of the gut microbiome on eye health
4
When treatment triggers uveitis
5